Clinical Trial Update: HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HSV-tk gene therapy in combination with radiotherapy and chemotherapy for newly diagnosed glioblastoma and anaplastic astr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• HSV-tk gene therapy

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Glioblastoma, Anaplastic Astrocytoma | Phase 1, Phase 2 | Status: RECRUITING